Evidence map›Paper›PMID 33287381›Full record

ArticleMaterials (Basel, Switzerland)2020

Strontium-Modified Scaffolds Based on Mesoporous Bioactive Glasses/Polyvinyl Alcohol Composites for Bone Regeneration.

Javier Jiménez-Holguín, Alvaro López-Hidalgo, Sandra Sánchez-Salcedo, Juan Peña, María Vallet-Regí, Antonio J Salinas

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. SrO-Containing Bioactive Glasses in the SiOACS biomaterials science & engineering · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Harnessing strontium in regenerative dentistry: progress and perspectives.Frontiers in bioengineering and biotechnology · 2025
    Review
  7. Article
  8. Article
  9. Nanomaterials (Basel, Switzerland) · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Javier Jiménez-HolguínDepartment of Química en Ciencias Farmacéuticas, Faculty of Farmacia, Universidad Complutense, UCM, Instituto de Investigación Hospital 12 de Octubre, imas12, 28040 Madrid, Spain.ORCID 0000-0002-0317-4984
Alvaro López-HidalgoDepartment of Química en Ciencias Farmacéuticas, Faculty of Farmacia, Universidad Complutense, UCM, Instituto de Investigación Hospital 12 de Octubre, imas12, 28040 Madrid, Spain.
Sandra Sánchez-SalcedoDepartment of Química en Ciencias Farmacéuticas, Faculty of Farmacia, Universidad Complutense, UCM, Instituto de Investigación Hospital 12 de Octubre, imas12, 28040 Madrid, Spain.ORCID 0000-0002-1889-2057
Juan PeñaDepartment of Química en Ciencias Farmacéuticas, Faculty of Farmacia, Universidad Complutense, UCM, Instituto de Investigación Hospital 12 de Octubre, imas12, 28040 Madrid, Spain.
María Vallet-RegíDepartment of Química en Ciencias Farmacéuticas, Faculty of Farmacia, Universidad Complutense, UCM, Instituto de Investigación Hospital 12 de Octubre, imas12, 28040 Madrid, Spain.ORCID 0000-0002-6104-4889
Antonio J SalinasDepartment of Química en Ciencias Farmacéuticas, Faculty of Farmacia, Universidad Complutense, UCM, Instituto de Investigación Hospital 12 de Octubre, imas12, 28040 Madrid, Spain.ORCID 0000-0002-8408-3389
Research Institute Hospital 12 de Octubre · ES

Funding

European Research Council (ERC-2015-AdG), Advanced Grant Verdi-Proposal No.694160Instituto de Salud Carlos III project co-financed with the European Union FEDER funds (PI15/00978)Youth Employment initiative (YEI) from Comunidad de Madrid PEJ-2017-2017-AI/SALl-5825
6 · The paper itself

Abstract

In the search of a new biomaterial for the treatment of bone defects resulting from traumatic events, an osteoporosis scenario with bone fractures, tumor removal, congenital pathologies or implant revisions for infection, we developed 3D scaffolds based on mesoporous bioactive glasses (MBGs) (85-x)SiO

Indexed as

cytocompatibilitymesoporous glass scaffoldspre-osteoblastic cellsSrO

Identifiers

PMID33287381
PMCPMC7731299
OpenAlexW3108255351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.